NutriBand (NTRB) Capital Leases (2020 - 2023)
NutriBand's (NTRB) quarterly Capital Leases came in at $34277.0 in Q1 2023, down 19.1% quarter-over-quarter from $42369.0 in Q4 2022.
NutriBand (NTRB) Capital Leases (2020 - 2023) Analysis & Trends
NutriBand has disclosed Capital Leases across 4 years of filings, most recently posting $34277.0 for Q1 2023.
- Capital Leases for Q1 2023 came in at $34277.0, changed N/A year-over-year; the trailing twelve-month figure through Jan 2023 was $34277.0 (changed N/A YoY), and the FY2023 annual result was $34277.0, changed N/A from the prior year.
- Capital Leases came in at $34277.0 for Q1 2023 at NutriBand, down from $42369.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $103688.0 in Q4 2020 to a low of $34277.0 in Q1 2023.
- The 4-year median for Capital Leases is $74712.5 (2021), against an average of $72814.0.
- Peak annual rise in Capital Leases reached 21.81% in 2022, while the deepest fall reached 27.45% in 2022.
- NutriBand's Capital Leases stood at $103688.0 in 2020, then dropped by 19.13% to $83856.0 in 2021, then tumbled by 49.47% to $42369.0 in 2022, then slipped by 19.1% to $34277.0 in 2023.
- The last three Capital Leases figures came in at $34277.0 (Q1 2023), $42369.0 (Q4 2022), and $65569.0 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2023 | 34,277.00 |
| Oct 31, 2022 | 42,369.00 |
| Jul 31, 2022 | 65,569.00 |
| Apr 30, 2022 | 65,569.00 |
| Jul 31, 2021 | 83,856.00 |
| Apr 30, 2021 | 90,380.00 |
| Jan 31, 2021 | 96,804.00 |
| Oct 31, 2020 | 103,688.00 |